CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
7689-03-4 | 喜樹(shù)堿 | (+)-camptothecin; 4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | ![]() | C20H16N2O4 | 詳情 | 供應(yīng)商 |
19685-09-7 | (S)-10-羥基喜樹(shù)堿 | (S)-10-Hydroxycamptothecin; (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; NSC 107124 | ![]() | C20H16N2O5 | 詳情 | 供應(yīng)商 |
22867-74-9 | 7-乙基吲哚 | 7-Ethylindole; 7-Ethylcamptothecin | ![]() | C10H11N | 詳情 | 供應(yīng)商 |
64439-81-2 | 10-羥基喜樹(shù)堿 | 10-Hydroxycamptothecin; (+/-)-4-Ethyl-4,9-dihydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | ![]() | C20H16N2O5 | 詳情 | 供應(yīng)商 |
67656-30-8 | 10-羥基喜樹(shù)堿; 4-乙基-4,10-二羥基-1H-吡喃[3',4':6,7]吲哚[1,2-b]喹啉-3,14(4H,12H)-二酮 | 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; 4-Ethyl-4,10-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | ![]() | C20H16N2O5 | 詳情 | 供應(yīng)商 |
78287-27-1 | 7-乙基喜樹(shù)堿 | 7-Ethylcamptothecin; (S)-4,11-Diethyl-4-hydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione | ![]() | C22H20N2O4 | 詳情 | 供應(yīng)商 |
86639-52-3 | 7-乙基-10-羥基喜樹(shù)堿 | 7-Ethyl-10-hydroxycamptothecin; 4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | ![]() | C22H20N2O5 | 詳情 | 供應(yīng)商 |
86639-62-5 | 9-硝基喜樹(shù)堿 | 9-Nitrocamptothecin; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-9-nitro-, (S)-; 10-Nitrocamptothecin | ![]() | C20H15N3O6 | 詳情 | 供應(yīng)商 |
91421-42-0 | 魯比特康; (4S)-4-乙基-4-羥基-10-硝基-1H-吡喃并[3',4':6,7]氮茚并[1,2-b]喹啉-3,14[4H,12H]-二酮 | Rubitecan; (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 9-Nitro-20(S)-camptothecin; 9-Nitrocamptothecin; Orathecin | ![]() | C20H15N3O6 | 詳情 | 供應(yīng)商 |
91421-43-1 | 9-氨基喜樹(shù)堿 | 9-Aminocamptothecin; 9-Amino-20-(S)-camptothecin; 10-Amino-4(S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | ![]() | C20H17N3O4 | 詳情 | 供應(yīng)商 |
123948-87-8 | 拓?fù)涮婵?/td> | Topotecan hydrochloride; 4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; 9-Dimethylaminomethyl-10-hydroxycamptothecin hydrochloride salt; Hycam | ![]() | C23H23N3O5 | 詳情 | 供應(yīng)商 |
86639-63-6 | 10-氨基喜樹(shù)堿 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,9-amino-4-ethyl-4-hydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,9-amino-4-ethyl-4-hydroxy-, (S)-; 10-Aminocamptothecin | ![]() | C20H17N3O4 | 詳情 | 供應(yīng)商 |
31456-25-4 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-, (?à)-; camptothecine, (?à)- (8CI); (?à)-camptothecin; (?à)-camptothecine; 20(RS)-camptothecin; NSC 302991; dl-camptothecin | ![]() | C20H16N2O4 | 詳情 | 供應(yīng)商 | |
130194-90-0 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,10-amino-4-ethyl-4-hydroxy-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,10-amino-4-ethyl-4-hydroxy-, (?à)-; (?à)-9-Aminocamptothecine; 9-Amino-20(RS)-camptothecin; NSC 629971 | ![]() | C20H17N3O4 | 詳情 | 供應(yīng)商 | |
172805-55-9 | 10-(2-(Tetrahydrofuran-2-carboxyamido)ethoxy)-20(R,S)-camptothecin | ![]() | 詳情 | 供應(yīng)商 | ||
110351-92-3 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-, (4R)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-, (R)-; (R)-(-)-camptothecin; (R)-(-)-camptothecine; (R)-camptothecin; 20R-camptothecin | ![]() | C20H16N2O4 | 詳情 | 供應(yīng)商 | |
185304-42-1 | 7-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin; 4-Amino-(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1-Piperidinecarboxylic Acid Ester; 7-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin; NPC (metabolite); RPR 132595A | 無(wú) | C28H30N4O6 | 詳情 | 供應(yīng)商 | |
181629-47-0 | RPR121056A; 4-[(4-Carboxybutyl)amino]-1-piperidinecarboxylic Acid (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl Ester Hydrochloride; 7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin Hydrochloride; RPR121056A | ![]() | C33H39ClN4O8 | 詳情 | 供應(yīng)商 | |
718612-49-8 | SN-38-D3; SN-38-D3; (4S)-4-(Ethyl-d3)-11-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxy-7-ethylcamptothecin-d3; 7-Ethyl-10-hydroxycamptothecin-d3; SN 38-d3 Lactone; (4S)-4-Ethyl-11-(ethyl-d3)-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | ![]() | C22H17D3N2O5 | 詳情 | 供應(yīng)商 | |
25387-67-1 | 喜樹(shù)堿鈉鹽 | SODIUM camptothecIN; 20(s)-camptothecinsodiumsalt; 21,22-secocamptothecin-21-oicacid,monosodiumsalt; camptothecin,sodiumsalt; camptothecinesodium; camptothecinsodium; SODIUM camptothecIN; (αS)-α-Ethyl-9,11-dihydro-α-hydroxy-8-(hydroxymethyl)-9-oxoindolizino[1,2-b]quinoline-7-acetic acid sodium salt; 21,22-Secocamptothecin-21-oic acid, monosodium salt 20(S)-camptothecin sodium salt | ![]() | C20H17N2NaO5 | 詳情 | 供應(yīng)商 |